NIH-funded research R01 grant

Lipocalin-2 and delirium after surgery in Alzheimer’s disease and related dementias

Official title: Defining the role of lipocalin-2 in postoperative delirium

Funded at Duke University · NIH-11464607 · Data updated 2026-11-12

A study at Duke University looks at how an inflammatory protein called lipocalin-2 may trigger delirium after surgery, especially in people at risk for Alzheimer’s and related dementias.

More Delirium research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 1, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$647,811
NIH project number1R01AG104704-01
Project IDNIH-11464607 on NIH RePORTER

Who could benefit from this research

Could help

Older adults undergoing orthopedic surgery who may be at risk for Alzheimer’s disease and related dementias, including those with neurodegenerative changes.

Less likely to help

People without a high risk of dementia or those not undergoing surgery may not benefit from these findings.

What this research studies

Delirium after surgery is common and can worsen long-term thinking abilities, particularly in older adults with dementia risk. This project builds on animal and human data to understand how lipocalin-2 and brain blood vessels interact to cause delirium around orthopedic procedures. By studying both postoperative samples from patients and a mouse model, researchers hope to map when and where inflammatory processes start to affect the brain. The goal is to identify targets that could lead to new treatments to prevent delirium and protect cognitive health after surgery.

Why it matters

Potential benefit: If successful, the work could lead to strategies to prevent or reduce delirium and its long-term cognitive consequences in older adults with dementia risk.

How similar studies have gone: Preclinical and patient studies have linked brain inflammation and delirium; this project builds on those findings with a focused mechanism involving LCN2.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Terrando, Niccolo — Duke University
  • Study coordinator: Terrando, Niccolo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.